Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
EJNMMI Physics
|
December 5, 2022
Quantitative [<sup>99m</sup>Tc]Tc-MDP SPECT/CT correlated with [<sup>18</sup>F]NaF PET/CT for bone metastases in patients with prostate cancer
Kenichi Tanaka, Takashi Norikane, Katsuya Mitamura, et al.
European Urology Oncology
|
August 1, 2024
De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium
Yoichiro Tohi, John M Sahrmann, Jaron Arbet, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 4, 2024
Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
Yuto Hattori, Tasuku Fujiwara, Hiroki Hagimoto, et al.
The Prostate
|
February 20, 2025
Impact of Neoadjuvant Chemohormonal Therapy With GnRH Antagonist and Low-Dose Estramustine in Very High-Risk Prostate Cancer Undergoing Robotic Radical Prostatectomy
Takanari Kambe, Masashi Kubota, Toshinari Yamasaki, et al.
International Journal of Clinical Oncology
|
March 8, 2025
Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)
Yoichiro Tohi, Akira Yokomizo, Takahiro Kimura, et al.
Asian Journal of Endoscopic Surgery
|
July 5, 2022
Effect of continued perioperative antithrombotic therapy on bleeding outcomes following laparoscopic nephrectomy and nephroureterectomy
Masashi Kubota, Takashi Matsuoka, Yuta Mine, et al.
International Journal of Clinical Oncology
|
May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
BMC Urology
|
September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study
Mikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
International Journal of Clinical Oncology
|
March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
Takuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 14, 2022
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan
Naoki Terada, Atsuro Sawada, Hiroaki Kawanishi, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
EJNMMI Physics
|
December 5, 2022
Quantitative [<sup>99m</sup>Tc]Tc-MDP SPECT/CT correlated with [<sup>18</sup>F]NaF PET/CT for bone metastases in patients with prostate cancer
Kenichi Tanaka, Takashi Norikane, Katsuya Mitamura, et al.
European Urology Oncology
|
August 1, 2024
De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium
Yoichiro Tohi, John M Sahrmann, Jaron Arbet, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
July 4, 2024
Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer
Yuto Hattori, Tasuku Fujiwara, Hiroki Hagimoto, et al.
The Prostate
|
February 20, 2025
Impact of Neoadjuvant Chemohormonal Therapy With GnRH Antagonist and Low-Dose Estramustine in Very High-Risk Prostate Cancer Undergoing Robotic Radical Prostatectomy
Takanari Kambe, Masashi Kubota, Toshinari Yamasaki, et al.
International Journal of Clinical Oncology
|
March 8, 2025
Nomogram predicting the outcome of salvage radiation therapy for prostate-specific antigen failure following radical prostatectomy: an exploratory analysis of a randomized, multicenter, open-label, phase 3 trial (JCOG0401)
Yoichiro Tohi, Akira Yokomizo, Takahiro Kimura, et al.
Asian Journal of Endoscopic Surgery
|
July 5, 2022
Effect of continued perioperative antithrombotic therapy on bleeding outcomes following laparoscopic nephrectomy and nephroureterectomy
Masashi Kubota, Takashi Matsuoka, Yuta Mine, et al.
International Journal of Clinical Oncology
|
May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
Yoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
BMC Urology
|
September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study
Mikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
International Journal of Clinical Oncology
|
March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
Takuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 14, 2022
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan
Naoki Terada, Atsuro Sawada, Hiroaki Kawanishi, et al.
Page
of 9